Stargardt’s disease: groundbreaking gene therapy study gives hope

In Stargardt disease, loss-of-function mutations in the ABCA4 gene lead to macular degeneration and blindness. A team led by researchers from the University of Basel has developed a promising new therapeutic approach. In their study, they were able to demonstrate precise gene correction using “base editing”. The results were published in the journal Nature Medicine.